A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples